,ARDSVEGFMSC

Courteney Tunstead1, Evelina Volkova1, Hazel Dunbar1

  • 1Cellular Immunology Lab, Department of Biology, Maynooth University, Maynooth, Co. Kildare, Ireland; Kathleen Lonsdale Institute for Human Health Research, Maynooth University, Maynooth, Co. Kildare, Ireland.

概括

在高炎症环境中预先授权介质细胞 (MSC) 增强它们对急性肺炎的疗效. 这种方法改善了小鼠的肺屏障完整性和临床结果,建议针对ARDS亚型量身定制的MSC治疗.